Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
23 hedge funds and large institutions have $5.28M invested in Fibrocell Science Inc. in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
30% more capital invested
Capital invested by funds: $4.06M → $5.28M (+$1.22M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less funds holding
Funds holding: 26 → 23 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$199K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53K |
| 3 |
Morgan Stanley
New York
|
+$50.6K |
| 4 |
ACA
Apis Capital Advisors
New York
|
+$49.8K |
| 5 |
VF
Virtu Financial
New York
|
+$37.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$137K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$64K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$32.6K |
| 4 |
Jane Street
New York
|
-$20K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |
FCSC Hedge Fund Activity: Q1 2019 in Review
23 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q1 2019, worth a combined $5.28M — up 30% from $4.06M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FCSC and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $199K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $137K sold.
- 23 institutional investors held Fibrocell Science Inc. (FCSC) as of Q1 2019, down from 26 in Q4 2018.
- Funds reported $5.28M of Fibrocell Science Inc. stock for Q1 2019, up 30% quarter-over-quarter.
- 1 fund opened new Fibrocell Science Inc. positions in Q1 2019 and 4 closed out, a net change of -3 holders.
- The largest Fibrocell Science Inc. buyer in Q1 2019 was Renaissance Technologies, an estimated $199K added.
- The largest Fibrocell Science Inc. seller in Q1 2019 was Oxford Asset Management, an estimated $137K sold.
Based on aggregated 13F filings for Q1 2019.